Page last updated: 2024-08-21

thiazoles and Leukemia, Lymphocytic, Chronic, T Cell

thiazoles has been researched along with Leukemia, Lymphocytic, Chronic, T Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adnan-Awad, S; Aittokallio, T; Anders, S; Andersson, EI; Bellanger, D; Brümmendorf, TH; Crispatzu, G; Cuesta-Mateos, C; Ding, W; Dufva, O; Eldfors, S; Ellonen, P; Faber, E; He, L; Herling, M; Huber, W; Kallioniemi, O; Khan, S; Koschmieder, S; Kytölä, S; Lagström, S; Lauhio, A; Mpindi, JP; Mustjoki, S; Oleś, M; Pemovska, T; Pietarinen, P; Pützer, S; Savolainen, ER; Schrader, A; Sellner, L; Siitonen, T; Stern, MH; Tang, J; Tomska, K; Wennerberg, K; Yadav, B; Zenz, T; Zhang, H1

Other Studies

1 other study(ies) available for thiazoles and Leukemia, Lymphocytic, Chronic, T Cell

ArticleYear
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.
    Leukemia, 2018, Volume: 32, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Chromosome Aberrations; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Gene Expression; Gene Expression Profiling; High-Throughput Screening Assays; Humans; Janus Kinases; Leukemia, Prolymphocytic, T-Cell; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Oxazoles; Phenotype; Protein Kinase Inhibitors; STAT Transcription Factors; Thiazoles

2018